Search PepX: activator
27 results
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1GWQ | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
 |
  |
1GWR | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
|
  |
1YCQ | XENOPUS LAEVIS MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF HUMAN P53 | B | A | SWIB/MDM2 domain |
|
  |
2J7X | STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | B | A | Nuclear receptor ligand-binding domain |
|
  |
2J7Y | STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | B | A | Nuclear receptor ligand-binding domain |
|
  |
2Z5S | Molecular basis for the inhibition of p53 by Mdmx | R | O |
|
|
  |
2Z5T | Molecular basis for the inhibition of p53 by Mdmx | P | MO |
|
|
  |
2ZFX | Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205 | C | A |
|
|
  |
2ZMH | Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZMI | Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZMJ | Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZXN | A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket | C | A |
|
|
  |
3BEJ | Structure of human FXR in complex with MFA-1 and co-activator peptide | E | A | Nuclear receptor ligand-binding domain |
|
  |
3C0T | Structure of the Schizosaccharomyces pombe Mediator subcomplex Med8C/18 | B | A |
|
|
  |
3CWD | Molecular recognition of nitro-fatty acids by PPAR gamma | C | A | Nuclear receptor ligand-binding domain |
|
  |
3DCT | FXR with SRC1 and GW4064 | B | A | Nuclear receptor ligand-binding domain |
|
  |
3E7C | Glucocorticoid Receptor LBD bound to GSK866 | D | B |
|
|
  |
3E94 | Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator fragment | B | A |
|
|
  |
3ET1 | Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | P | A |
|
|
  |
3ET3 | Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | P | A |
|
|
  |
3F7D | SF-1 LBD bound by phosphatidylcholine | B | A |
|
|
  |
3FUG | Crystal Structure of the Retinoid X Receptor Ligand Binding Domain Bound to the Synthetic Agonist 3-[4-Hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-phenyl]acrylic Acid | B | A |
|
|
  |
3FUR | Crystal Structure of PPARg in complex with INT131 | H | A |
|
|
  |
3FXV | Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist | B | A |
|
|
  |
3G8I | Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes | Z | A |
|
|
  |
3G9E | Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | B | A |
|
|
  |
3H0A | Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist | B | A |
|
